![](https://webarchive.library.unt.edu/eot2008/20090118123522im_/http://www.fda.gov/cder/templates/graphics/dot_clear.gif) |
Prescription and Over-the-Counter Drug Product List
27th Edition
Cumulative Supplement Number 5: May 2007
NOTE: The format for the Monthly Additions/Deletions Drug
Product List changed as of the July Cumulative Supplement (CS) of the 21st
Edition to mirror the CS. Refer to the CS Preface section 1.6
Cumulative Supplement Legend. ![PDF](https://webarchive.library.unt.edu/eot2008/20090118123522im_/http://www.fda.gov/cder/graphics/pdf.gif)
ACETAMINOPHEN; HYDROCODONE BITARTRATE
TABLET; ORAL
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
>D> AA UCB INC 500MG;10MG N40210 001 Aug 13, 1997 May DISC
>A> @ 500MG;10MG N40210 001 Aug 13, 1997 May DISC
>D> AA 650MG;7.5MG N40134 001 Nov 21, 1996 May DISC
>A> @ 650MG;7.5MG N40134 001 Nov 21, 1996 May DISC
ACETAZOLAMIDE
CAPSULE, EXTENDED RELEASE; ORAL
DIAMOX
>D> @ DURAMED PHARMS 500MG N12945 001 May CMFD
>A> + 500MG N12945 001 May CMFD
ALBUTEROL SULFATE
SOLUTION; INHALATION
ALBUTEROL SULFATE
>D> AN ROXANE EQ 0.083% BASE N75129 001 Feb 13, 2001 May DISC
>A> @ EQ 0.083% BASE N75129 001 Feb 13, 2001 May DISC
ALLOPURINOL SODIUM
INJECTABLE; INJECTION
ALOPRIM
>A> AP + BIONICHE PHARMA EQ 500MG BASE/VIAL N20298 001 May 17, 1996 May CAHN
>D> AP + NABI EQ 500MG BASE/VIAL N20298 001 May 17, 1996 May CAHN
ALPRAZOLAM
TABLET, EXTENDED RELEASE; ORAL
ALPRAZOLAM
>A> AB IMPAX LABS 0.5MG N77968 004 May 24, 2007 May NEWA
>A> AB 1MG N77968 003 May 24, 2007 May NEWA
>A> AB 2MG N77968 002 May 24, 2007 May NEWA
>A> AB 3MG N77968 001 May 24, 2007 May NEWA
AMIODARONE HYDROCHLORIDE
INJECTABLE; INJECTION
>D> CORDARONE
>D> AP + WYETH PHARMS 50MG/ML N20377 001 Aug 03, 1995 May DISC
>A> @ 50MG/ML N20377 001 Aug 03, 1995 May DISC
AMLODIPINE BESYLATE
TABLET; ORAL
AMLODIPINE BESYLATE
>A> AB APOTEX EQ 2.5MG BASE N76719 001 May 23, 2007 May NEWA
>A> AB EQ 5MG BASE N76719 002 May 23, 2007 May NEWA
>A> AB EQ 10MG BASE N76719 003 May 23, 2007 May NEWA
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
CAPSULE; ORAL
>A> AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
>A> AB TEVA PHARMS EQ 2.5MG BASE;10MG N77179 001 May 18, 2007 May NEWA
>A> AB EQ 5MG BASE;10MG N77179 002 May 18, 2007 May NEWA
>A> AB EQ 5MG BASE;20MG N77179 003 May 18, 2007 May NEWA
>A> AB EQ 10MG BASE;20MG N77179 004 May 18, 2007 May NEWA
LOTREL
>D> NOVARTIS EQ 2.5MG BASE;10MG N20364 002 Mar 03, 1995 May CFTG
>A> AB EQ 2.5MG BASE;10MG N20364 002 Mar 03, 1995 May CFTG
>D> EQ 5MG BASE;10MG N20364 003 Mar 03, 1995 May CFTG
>A> AB EQ 5MG BASE;10MG N20364 003 Mar 03, 1995 May CFTG
>D> EQ 5MG BASE;20MG N20364 004 Mar 03, 1995 May CFTG
>A> AB EQ 5MG BASE;20MG N20364 004 Mar 03, 1995 May CFTG
>D> EQ 10MG BASE;20MG N20364 005 Jun 20, 2002 May CFTG
>A> AB EQ 10MG BASE;20MG N20364 005 Jun 20, 2002 May CFTG
AMOXICILLIN
CAPSULE; ORAL
>D> TRIMOX
>D> AB APOTHECON 250MG N61885 001 May DISC
>A> @ 250MG N61885 001 May DISC
>D> AB 500MG N61885 002 May DISC
>A> @ 500MG N61885 002 May DISC
AZACITIDINE
>A> INJECTABLE; IV-SC
>A> VIDAZA
>A> + PHARMION 100MG/VIAL N50794 001 May 19, 2004 May CDFR
>D> INJECTABLE; SUBCUTANEOUS
>D> VIDAZA
>D> + PHARMION 100MG/VIAL N50794 001 May 19, 2004 May CDFR
AZITHROMYCIN
INJECTABLE; INJECTION
AZITHROMYCIN
>D> AP + SICOR PHARMS EQ 500MG BASE/VIAL N50809 001 Dec 19, 2006 May CAHN
>D> + EQ 2.5GM BASE/VIAL N50809 002 Dec 19, 2006 May CAHN
>A> AP + TEVA PARENTERAL EQ 500MG BASE/VIAL N50809 001 Dec 19, 2006 May CAHN
>A> + EQ 2.5GM BASE/VIAL N50809 002 Dec 19, 2006 May CAHN
SOLUTION/DROPS; OPHTHALMIC
AZASITE
>D> + INSITE VISION 1% N50810 001 Apr 27, 2007 May CAHN
>A> + INSPIRE 1% N50810 001 Apr 27, 2007 May CAHN
TABLET; ORAL
AZITHROMYCIN
>A> AB MYLAN EQ 250MG BASE N65365 001 May 30, 2007 May NEWA
>A> AB EQ 500MG BASE N65366 001 May 30, 2007 May NEWA
BETAMETHASONE DIPROPIONATE
LOTION, AUGMENTED; TOPICAL
>A> BETAMETHASONE DIPROPIONATE
>A> AB ALTANA EQ 0.05% BASE N77111 001 May 21, 2007 May NEWA
>A> AB TARO EQ 0.05% BASE N77477 001 May 21, 2007 May NEWA
DIPROLENE
>D> + SCHERING EQ 0.05% BASE N19716 001 Aug 01, 1988 May CFTG
>A> AB + EQ 0.05% BASE N19716 001 Aug 01, 1988 May CFTG
>D> BISKALCITRATE; METRONIDAZOLE; TETRACYCLINE
>D> CAPSULE; ORAL
>D> PYLERA
>D> + AXCAN 140MG;125MG;125MG N50786 001 Sep 28, 2006 May CAIN
>A> BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE
>A> CAPSULE; ORAL
>A> PYLERA
>A> + AXCAN 140MG;125MG;125MG N50786 001 Sep 28, 2006 May CAIN
BUPIVACAINE HYDROCHLORIDE
INJECTABLE; INJECTION
SENSORCAINE
>A> AP ABRAXIS 0.25% N70552 001 May 21, 1986 May CAHN
>A> AP 0.25% N18304 001 May CAHN
>A> AP 0.5% N70553 001 May 21, 1986 May CAHN
>A> AP 0.5% N18304 002 May CAHN
>A> AP 0.75% N70554 001 May 21, 1986 May CAHN
>A> AP 0.75% N18304 003 May CAHN
>D> AP ASTRAZENECA 0.25% N70552 001 May 21, 1986 May CAHN
>D> AP 0.25% N18304 001 May CAHN
>D> AP 0.5% N70553 001 May 21, 1986 May CAHN
>D> AP 0.5% N18304 002 May CAHN
>D> AP 0.75% N70554 001 May 21, 1986 May CAHN
>D> AP 0.75% N18304 003 May CAHN
INJECTABLE; SPINAL
SENSORCAINE
>A> AP ABRAXIS 0.75% N71202 001 Apr 15, 1987 May CAHN
>D> AP ASTRAZENECA 0.75% N71202 001 Apr 15, 1987 May CAHN
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
INJECTABLE; INJECTION
SENSORCAINE
>A> AP ABRAXIS 0.25%;0.0091MG/ML N70967 001 Oct 13, 1987 May CAHN
>A> AP 0.25%;0.0091MG/ML N70966 001 Oct 13, 1987 May CAHN
>A> AP 0.5%;0.0091MG/ML N70968 001 Oct 13, 1987 May CAHN
>A> AP 0.5%;0.0091MG/ML N18304 004 Sep 02, 1983 May CAHN
>A> AP 0.75%;0.0091MG/ML N18304 005 Sep 02, 1983 May CAHN
>D> AP ASTRAZENECA 0.25%;0.0091MG/ML N70967 001 Oct 13, 1987 May CAHN
>D> AP 0.25%;0.0091MG/ML N70966 001 Oct 13, 1987 May CAHN
>D> AP 0.5%;0.0091MG/ML N70968 001 Oct 13, 1987 May CAHN
>D> AP 0.5%;0.0091MG/ML N18304 004 Sep 02, 1983 May CAHN
>D> AP 0.75%;0.0091MG/ML N18304 005 Sep 02, 1983 May CAHN
CAFFEINE CITRATE
SOLUTION; INTRAVENOUS
CAFFEINE CITRATE
>A> AP LUITPOLD EQ 30MG BASE/3ML (EQ 10MG N77906 001 May 15, 2007 May NEWA
CEFACLOR
CAPSULE; ORAL
CEFACLOR
>D> AB TEVA EQ 250MG BASE N64145 001 Jun 24, 1996 May DISC
>A> @ EQ 250MG BASE N64145 001 Jun 24, 1996 May DISC
>D> AB EQ 500MG BASE N64145 002 Jun 24, 1996 May DISC
>A> @ EQ 500MG BASE N64145 002 Jun 24, 1996 May DISC
CEFADROXIL/CEFADROXIL HEMIHYDRATE
CAPSULE; ORAL
CEFADROXIL
>D> AB AUROBINDO 500MG N65352 001 Jan 25, 2007 May CPOT
>A> AB EQ 500MG BASE N65352 001 Jan 25, 2007 May CPOT
>A> AB LUPIN EQ 500MG BASE N65392 001 May 29, 2007 May NEWA
CEFAZOLIN SODIUM
INJECTABLE; INJECTION
CEFAZOLIN SODIUM
>A> AP SANDOZ EQ 1GM BASE/VIAL N65345 001 May 09, 2007 May NEWA
CEFDINIR
CAPSULE; ORAL
CEFDINIR
>A> AB TEVA PHARMS 300MG N65368 001 May 09, 2007 May NEWA
CEFPROZIL
TABLET; ORAL
CEFPROZIL
>A> AB AUROBINDO 250MG N65340 001 May 24, 2007 May NEWA
>A> AB 500MG N65340 002 May 24, 2007 May NEWA
CEPHALEXIN
FOR SUSPENSION; ORAL
CEPHALEXIN
>D> + CEPH INTL EQ 100MG BASE/ML N62117 001 May DISC
>A> @ EQ 100MG BASE/ML N62117 001 May DISC
>D> AB TEVA EQ 125MG BASE/5ML N62767 001 Jun 16, 1987 May DISC
>A> @ EQ 125MG BASE/5ML N62767 001 Jun 16, 1987 May DISC
>D> AB EQ 250MG BASE/5ML N62768 001 Jun 16, 1987 May DISC
>A> @ EQ 250MG BASE/5ML N62768 001 Jun 16, 1987 May DISC
>D> CEPHRADINE
>D> CAPSULE; ORAL
>D> CEPHRADINE
>D> TEVA 250MG N62683 001 Jan 09, 1987 May DISC
>A> @ 250MG N62683 001 Jan 09, 1987 May DISC
>D> + 500MG N62683 002 Jan 09, 1987 May DISC
>A> @ 500MG N62683 002 Jan 09, 1987 May DISC
>D> FOR SUSPENSION; ORAL
>D> ANSPOR
>D> AB GLAXOSMITHKLINE 125MG/5ML N61866 001 May DISC
>A> @ 125MG/5ML N61866 001 May DISC
>D> AB 250MG/5ML N61866 002 May DISC
>A> @ 250MG/5ML N61866 002 May DISC
>D> CEPHRADINE
>D> AB TEVA 125MG/5ML N62693 001 Jan 09, 1987 May DISC
>A> @ 125MG/5ML N62693 001 Jan 09, 1987 May DISC
>D> AB 250MG/5ML N62693 002 Jan 09, 1987 May DISC
>A> @ 250MG/5ML N62693 002 Jan 09, 1987 May DISC
>D> VELOSEF '125'
>D> AB + APOTHECON 125MG/5ML N61763 001 May DISC
>A> @ 125MG/5ML N61763 001 May DISC
>D> VELOSEF '250'
>D> AB + APOTHECON 250MG/5ML N61763 002 May DISC
>A> @ 250MG/5ML N61763 002 May DISC
CITALOPRAM HYDROBROMIDE
TABLET; ORAL
CITALOPRAM HYDROBROMIDE
>D> AB ROXANE EQ 10MG BASE N77041 001 Nov 23, 2004 May DISC
>A> @ EQ 10MG BASE N77041 001 Nov 23, 2004 May DISC
>D> AB EQ 20MG BASE N77041 002 Nov 23, 2004 May DISC
>A> @ EQ 20MG BASE N77041 002 Nov 23, 2004 May DISC
CLINDAMYCIN PHOSPHATE
INJECTABLE; INJECTION
CLINDAMYCIN PHOSPHATE
>A> AP ABRAXIS PHARM EQ 150MG BASE/ML N65347 001 May 09, 2007 May NEWA
CLOCORTOLONE PIVALATE
CREAM; TOPICAL
CLODERM
>A> + CORIA 0.1% N17765 001 May CAHN
>D> + HEALTHPOINT 0.1% N17765 001 May CAHN
CLOZAPINE
TABLET, ORALLY DISINTEGRATING; ORAL
FAZACLO ODT
>A> AVANIR PHARMS 12.5MG N21590 004 May 30, 2007 May NEWA
CROMOLYN SODIUM
SOLUTION; INHALATION
CROMOLYN SODIUM
>D> AN ROXANE 10MG/ML N75175 001 Sep 30, 1999 May DISC
>A> @ 10MG/ML N75175 001 Sep 30, 1999 May DISC
DALTEPARIN SODIUM
>D> INJECTABLE; INJECTION
>D> FRAGMIN
>D> + PHARMACIA AND 2,500 IU/0.2ML N20287 001 Dec 22, 1994 May CDFR
>D> + 5,000 IU/0.2ML N20287 003 Mar 18, 1996 May CDFR
>D> + 7,500 IU/0.3ML N20287 005 Apr 04, 2002 May CDFR
>D> + 10,000 IU/ML N20287 004 Jan 30, 1998 May CDFR
>D> + 95,000IU/3.8ML(25,000IU/ML) N20287 006 Apr 04, 2002 May CDFR
>D> + 95,000IU/9.5ML(10,000IU/ML) N20287 007 Apr 04, 2002 May CDFR
>A> INJECTABLE; SUBCUTANEOUS
>A> FRAGMIN
>A> + PHARMACIA AND 2,500IU/0.2ML (12,500IU/ML) N20287 001 Dec 22, 1994 May CDFR
>A> + 5,000IU/0.2ML (25,000IU/ML) N20287 003 Mar 18, 1996 May CDFR
>A> + 7,500IU/0.3ML (25,000IU/ML) N20287 005 Apr 04, 2002 May CDFR
>A> + 10,000IU/0.4ML (25,000IU/ML) N20287 002 May 01, 2007 May NEWA
>A> + 10,000IU/ML (10,000IU/ML) N20287 004 Jan 30, 1998 May CDFR
>A> + 12,500IU/0.5ML (25,000IU/ML) N20287 009 May 01, 2007 May NEWA
>A> + 15,000IU/0.6ML (25,000IU/ML) N20287 010 May 01, 2007 May NEWA
>A> + 18,000IU/0.72ML (25,000IU/ML) N20287 011 May 01, 2007 May NEWA
>A> + 95,000IU/3.8ML(25,000IU/ML) N20287 006 Apr 04, 2002 May CDFR
>A> + 95,000IU/9.5ML(10,000IU/ML) N20287 007 Apr 04, 2002 May CDFR
DAPSONE
GEL; TOPICAL
ACZONE
>A> @ QLT USA 5% N21794 001 Jul 07, 2005 May CAHN
>D> @ TOLMAR 5% N21794 001 Jul 07, 2005 May CAHN
DEFEROXAMINE MESYLATE
INJECTABLE; INJECTION
DEFEROXAMINE MESYLATE
>A> AP BEDFORD 500MG/VIAL N78086 001 May 30, 2007 May NEWA
>A> AP 2GM/VIAL N78086 002 May 30, 2007 May NEWA
DESONIDE
CREAM; TOPICAL
>A> DESONIDE
>A> AB + PERRIGO NEW YORK 0.05% N17010 001 May CTNA
>D> TRIDESILON
>D> AB + PERRIGO NEW YORK 0.05% N17010 001 May CTNA
OINTMENT; TOPICAL
>A> DESONIDE
>A> AB + PERRIGO NEW YORK 0.05% N17426 001 May CTNA
>D> TRIDESILON
>D> AB + PERRIGO NEW YORK 0.05% N17426 001 May CTNA
DIAZOXIDE
SUSPENSION; ORAL
PROGLYCEM
>D> + BAKER NORTON 50MG/ML N17453 001 May CAHN
>A> + IVAX RES 50MG/ML N17453 001 May CAHN
DIFLORASONE DIACETATE
OINTMENT; TOPICAL
>D> FLORONE
>D> @ PHARMACIA AND 0.05% N17994 001 May CTNA
>A> PSORCON E
>A> @ PHARMACIA AND 0.05% N17994 001 May CTNA
ECONAZOLE NITRATE
CREAM; TOPICAL
ECONAZOLE NITRATE
>D> AB HEALTHPOINT 1% N76574 001 Dec 17, 2004 May CAHN
>A> AB PRASCO 1% N76574 001 Dec 17, 2004 May CAHN
ENALAPRILAT
INJECTABLE; INJECTION
VASOTEC
>D> @ BIOVAIL LABS INTL 1.25MG/ML N19309 001 Feb 09, 1988 May CMFD
>A> AP + 1.25MG/ML N19309 001 Feb 09, 1988 May CMFD
ERYTHROMYCIN
OINTMENT; TOPICAL
AKNE-MYCIN
>A> + CORIA 2% N50584 001 Jan 10, 1985 May CAHN
>D> + HEALTHPOINT 2% N50584 001 Jan 10, 1985 May CAHN
SWAB; TOPICAL
>D> C-SOLVE-2
>D> AT IVAX PHARMS 2% N62751 001 Jul 30, 1993 May DISC
>A> @ 2% N62751 001 Jul 30, 1993 May DISC
>D> ERYCETTE
>D> AT + J AND J 2% N50594 001 Feb 15, 1985 May DISC
>A> @ 2% N50594 001 Feb 15, 1985 May DISC
ERYTHROMYCIN
>D> AT ALTANA 2% N65320 001 Jul 25, 2006 May CRLD
>A> AT + 2% N65320 001 Jul 25, 2006 May CRLD
>D> AT STIEFEL 2% N64128 001 Jul 03, 1996 May DISC
>A> @ 2% N64128 001 Jul 03, 1996 May DISC
>D> AT 2% N64126 001 Jul 03, 1996 May CRLD
>A> AT + 2% N64126 001 Jul 03, 1996 May CRLD
ESTAZOLAM
TABLET; ORAL
ESTAZOLAM
>D> AB TEVA 2MG N74921 002 Jul 10, 1997 May CRLD
>A> AB + 2MG N74921 002 Jul 10, 1997 May CRLD
ETHINYL ESTRADIOL; LEVONORGESTREL
TABLET; ORAL
>A> LYBREL
>A> + WYETH PHARMS 0.02MG;0.09MG N21864 001 May 22, 2007 May NEWA
FLUOXETINE HYDROCHLORIDE
CAPSULE; ORAL
FLUOXETINE
>A> AB MYLAN EQ 40MG BASE N75207 003 May 25, 2007 May NEWA
>A> FORMOTEROL FUMARATE
>A> SOLUTION; INHALATION
>A> PERFOROMIST
>A> + DEY LP 0.02MG/2ML N22007 001 May 11, 2007 May NEWA
GABAPENTIN
CAPSULE; ORAL
GABAPENTIN
>A> AB WATSON LABS 100MG N75485 003 May 11, 2007 May NEWA
>A> AB 300MG N75485 002 May 11, 2007 May NEWA
>A> AB 400MG N75485 001 May 11, 2007 May NEWA
GEMFIBROZIL
TABLET; ORAL
GEMFIBROZIL
>A> AB IMPAX PHARMS 600MG N78207 001 Jun 01, 2007 May NEWA
HISTRELIN ACETATE
IMPLANT; SUBCUTANEOUS
>A> SUPPRELIN LA
>A> + INDEVUS 50MG N22058 001 May 03, 2007 May NEWA
HYDROCORTISONE BUTYRATE
>A> LOTION; TOPICAL
>A> LOCOID
>A> + FERNDALE LABS 0.1% N22076 001 May 18, 2007 May NEWA
IDARUBICIN HYDROCHLORIDE
INJECTABLE; INJECTION
IDARUBICIN HYDROCHLORIDE
>A> AP BEDFORD LABS 1MG/ML N65288 001 May 15, 2007 May NEWA
INDIUM IN-111 CHLORIDE
INJECTABLE; INJECTION
INDICLOR
>D> + AMERSHAM 2mCi/0.2ML N19862 001 Dec 29, 1992 May CAHN
>A> + GE HEALTHCARE 2mCi/0.2ML N19862 001 Dec 29, 1992 May CAHN
INSULIN GLULISINE RECOMBINANT
>A> INJECTABLE; IV (INFUSION)-SC
>A> APIDRA
>A> + SANOFI AVENTIS US 1000 UNITS/10ML (100 UNITS/ML) N21629 001 Apr 16, 2004 May CDFR
>A> + 300 UNITS/3ML (100 UNITS/ML) N21629 002 Dec 20, 2005 May CDFR
>D> INJECTABLE; SUBCUTANEOUS
>D> APIDRA
>D> + SANOFI AVENTIS US 1000 UNITS/10ML (100 UNITS/ML) N21629 001 Apr 16, 2004 May CDFR
>D> + 300 UNITS/3ML (100 UNITS/ML) N21629 002 Dec 20, 2005 May CDFR
LEUCOVORIN CALCIUM
INJECTABLE; INJECTION
LEUCOVORIN CALCIUM
>D> AP PHARMACHEMIE EQ 350MG BASE/VIAL N40262 001 Dec 15, 1999 May DISC
>A> @ EQ 350MG BASE/VIAL N40262 001 Dec 15, 1999 May DISC
>D> AP PHARMACHEMIE USA EQ 50MG BASE/VIAL N89628 001 Apr 17, 1997 May DISC
>A> @ EQ 50MG BASE/VIAL N89628 001 Apr 17, 1997 May DISC
>A> LEVOCETIRIZINE DIHYDROCHLORIDE
>A> TABLET; ORAL
>A> XYZAL
>A> + UCB INC 5MG N22064 001 May 25, 2007 May NEWA
LISDEXAMFETAMINE DIMESYLATE
CAPSULE; ORAL
VYVANSE
>D> NEW RIVER 30MG N21977 001 Feb 23, 2007 May CAHN
>D> 50MG N21977 002 Feb 23, 2007 May CAHN
>D> + 70MG N21977 003 Feb 23, 2007 May CAHN
>A> NEW RIVER 30MG N21977 001 Feb 23, 2007 May CAHN
>A> 50MG N21977 002 Feb 23, 2007 May CAHN
>A> + 70MG N21977 003 Feb 23, 2007 May CAHN
MAFENIDE ACETATE
CREAM; TOPICAL
SULFAMYLON
>D> + MYLAN BERTEK EQ 85MG BASE/GM N16763 001 May CAHN
>A> + UDL LABS EQ 85MG BASE/GM N16763 001 May CAHN
FOR SOLUTION; TOPICAL
SULFAMYLON
>D> + MYLAN BERTEK 5% N19832 003 Jun 05, 1998 May CAHN
>A> + UDL LABS 5% N19832 003 Jun 05, 1998 May CAHN
MEPIVACAINE HYDROCHLORIDE
INJECTABLE; INJECTION
POLOCAINE
>A> AP ABRAXIS 1% N89407 001 Dec 01, 1986 May CAHN
>A> AP 2% N89410 001 Dec 01, 1986 May CAHN
>D> AP ASTRAZENECA 1% N89407 001 Dec 01, 1986 May CAHN
>D> AP 2% N89410 001 Dec 01, 1986 May CAHN
POLOCAINE-MPF
>A> AP ABRAXIS 1% N89406 001 Dec 01, 1986 May CAHN
>A> AP 1.5% N89408 001 Dec 01, 1986 May CAHN
>A> AP 2% N89409 001 Dec 01, 1986 May CAHN
>D> AP ASTRAZENECA 1% N89406 001 Dec 01, 1986 May CAHN
>D> AP 1.5% N89408 001 Dec 01, 1986 May CAHN
>D> AP 2% N89409 001 Dec 01, 1986 May CAHN
>A> MERCAPTOPURINE
>A> TABLET; ORAL
>A> MERCAPTOPURINE
>A> AB MYLAN 50MG N40594 001 Jul 01, 2005 May CAIN
>D> MERCAPTOPURINE ANHYDROUS
>D> TABLET; ORAL
>D> MERCAPTOPURINE
>D> AB MYLAN 50MG N40594 001 Jul 01, 2005 May CAIN
>A> METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE
>A> TABLET; ORAL
>A> ACTOPLUS MET
>A> TAKEDA GLOBAL 500MG;EQ 15MG BASE N21842 001 Aug 29, 2005 May CAIN
>A> + 850MG;EQ 15MG BASE N21842 002 Aug 29, 2005 May CAIN
>D> METFORMIN; PIOGLITAZONE HYDROCHLORIDE
>D> TABLET; ORAL
>D> ACTOPLUS MET
>D> TAKEDA GLOBAL 500MG;EQ 15MG BASE N21842 001 Aug 29, 2005 May CAIN
>D> + 850MG;EQ 15MG BASE N21842 002 Aug 29, 2005 May CAIN
METHADONE HYDROCHLORIDE
TABLET; ORAL
METHADONE HYDROCHLORIDE
>D> AA ROXANE 5MG N88108 001 Mar 08, 1983 May DISC
>A> @ 5MG N88108 001 Mar 08, 1983 May DISC
>D> AA 10MG N88109 001 Mar 08, 1983 May DISC
>A> @ 10MG N88109 001 Mar 08, 1983 May DISC
>D> AA 40MG N74081 001 Apr 28, 1995 May DISC
>A> @ 40MG N74081 001 Apr 28, 1995 May DISC
METHYLPHENIDATE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL
METADATE CD
>D> BX + UCB INC 30MG N21259 002 Jun 19, 2003 May CRLD
>A> BX 30MG N21259 002 Jun 19, 2003 May CRLD
METOLAZONE
TABLET; ORAL
METOLAZONE
>D> AB ROXANE 10MG N76482 002 Apr 29, 2004 May DISC
>A> @ 10MG N76482 002 Apr 29, 2004 May DISC
METOPROLOL SUCCINATE
TABLET, EXTENDED RELEASE; ORAL
METOPROLOL SUCCINATE
>A> AB KV PHARM EQ 100MG TARTRATE N76640 002 May 18, 2007 May NEWA
>A> AB EQ 200MG TARTRATE N76640 001 May 18, 2007 May NEWA
>A> AB SANDOZ EQ 50MG TARTRATE N76969 002 May 18, 2007 May NEWA
TOPROL-XL
>D> + ASTRAZENECA EQ 50MG TARTRATE N19962 001 Jan 10, 1992 May CFTG
>A> AB + EQ 50MG TARTRATE N19962 001 Jan 10, 1992 May CFTG
>D> EQ 100MG TARTRATE N19962 002 Jan 10, 1992 May CFTG
>A> AB EQ 100MG TARTRATE N19962 002 Jan 10, 1992 May CFTG
>D> + EQ 200MG TARTRATE N19962 003 Jan 10, 1992 May CFTG
>A> AB + EQ 200MG TARTRATE N19962 003 Jan 10, 1992 May CFTG
METOPROLOL TARTRATE
INJECTABLE; INJECTION
METOPROLOL TARTRATE
>A> AP HIKMA 1MG/ML N77761 001 May 30, 2007 May NEWA
MORPHINE SULFATE
INJECTABLE; INJECTION
ASTRAMORPH PF
>A> AP ABRAXIS 0.5MG/ML N71051 001 Oct 07, 1986 May CAHN
>A> AP 0.5MG/ML N71050 001 Oct 07, 1986 May CAHN
>A> AP 1MG/ML N71053 001 Oct 07, 1986 May CAHN
>A> AP 1MG/ML N71052 001 Oct 07, 1986 May CAHN
>D> AP ASTRAZENECA 0.5MG/ML N71051 001 Oct 07, 1986 May CAHN
>D> AP 0.5MG/ML N71050 001 Oct 07, 1986 May CAHN
>D> AP 1MG/ML N71053 001 Oct 07, 1986 May CAHN
>D> AP 1MG/ML N71052 001 Oct 07, 1986 May CAHN
OXYBUTYNIN CHLORIDE
TABLET, EXTENDED RELEASE; ORAL
OXYBUTYNIN CHLORIDE
>A> AB IMPAX PHARMS 5MG N76745 002 May 09, 2007 May NEWA
>A> AB 10MG N76745 003 May 09, 2007 May NEWA
>A> AB MYLAN 15MG N78293 001 May 10, 2007 May NEWA
OXYCODONE HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
OXYCONTIN
>D> PURDUE PHARMA LP 15MG N20553 006 Sep 18, 2006 May DISC
>A> @ 15MG N20553 006 Sep 18, 2006 May DISC
>D> 30MG N20553 007 Sep 18, 2006 May DISC
>A> @ 30MG N20553 007 Sep 18, 2006 May DISC
>D> 60MG N20553 008 Sep 18, 2006 May DISC
>A> @ 60MG N20553 008 Sep 18, 2006 May DISC
POLYETHYLENE GLYCOL 3350
FOR SOLUTION; ORAL
POLYETHYLENE GLYCOL 3350
>D> AA COASTAL PHARMS 17GM/SCOOPFUL N77893 001 May 26, 2006 May CAHN
>A> AA PADDOCK 17GM/SCOOPFUL N77893 001 May 26, 2006 May CAHN
POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM
FOR SUSPENSION; ORAL
GO-EVAC
>A> AA BOCA PHARMA 236GM/BOT;2.97GM/BOT;6.74GM/BOT; N73433 001 Apr 28, 1992 May CAHN
>D> AA COPLEY PHARM 236GM/BOT;2.97GM/BOT;6.74GM/BOT; N73433 001 Apr 28, 1992 May CAHN
PRAVASTATIN SODIUM
TABLET; ORAL
PRAVASTATIN SODIUM
>A> AB GLENMARK 10MG N77987 001 May 11, 2007 May NEWA
>A> AB 20MG N77987 002 May 11, 2007 May NEWA
>A> AB 40MG N77987 003 May 11, 2007 May NEWA
PROPRANOLOL HYDROCHLORIDE
>D> CONCENTRATE; ORAL
>D> PROPRANOLOL HYDROCHLORIDE INTENSOL
>D> + ROXANE 80MG/ML N71388 001 May 15, 1987 May DISC
>A> @ 80MG/ML N71388 001 May 15, 1987 May DISC
QUETIAPINE FUMARATE
>A> TABLET, EXTENDED RELEASE; ORAL
>A> SEROQUEL XR
>A> ASTRAZENECA 50MG N22047 001 May 17, 2007 May NEWA
>A> 200MG N22047 002 May 17, 2007 May NEWA
>A> 300MG N22047 003 May 17, 2007 May NEWA
>A> + 400MG N22047 004 May 17, 2007 May NEWA
>A> ROTIGOTINE
>A> FILM, EXTENDED RELEASE; TRANSDERMAL
>A> NEUPRO
>A> SCHWARZ 2MG/24HR N21829 001 May 09, 2007 May NEWA
>A> 4MG/24HR N21829 002 May 09, 2007 May NEWA
>A> + 6MG/24HR N21829 003 May 09, 2007 May NEWA
SIMVASTATIN
TABLET; ORAL
SIMVASTATIN
>A> AB LUPIN 10MG N78103 001 May 11, 2007 May NEWA
>A> AB 20MG N78103 002 May 11, 2007 May NEWA
>A> AB 40MG N78103 003 May 11, 2007 May NEWA
>A> AB 80MG N78103 004 May 11, 2007 May NEWA
TAMOXIFEN CITRATE
TABLET; ORAL
TAMOXIFEN CITRATE
>D> AB PHARMACHEMIE EQ 20MG BASE N74858 001 Feb 20, 2003 May CRLD
>A> AB + TEVA PHARMS EQ 20MG BASE N74858 001 Feb 20, 2003 May CRLD
TECHNETIUM TC-99M SESTAMIBI KIT
INJECTABLE; INJECTION
>D> MIRALUMA
>D> + BRISTOL MYERS N/A N19785 003 May 23, 1997 May DISC
>A> @ N/A N19785 003 May 23, 1997 May DISC
>A> TEMSIROLIMUS
>A> SOLUTION; INTRAVENOUS
>A> TORISEL
>A> + WYETH PHARMS 25MG/ML (25MG/ML) N22088 001 May 30, 2007 May NEWA
TESTOSTERONE
GEL; TRANSDERMAL
TESTOSTERONE
>A> AB PAR PHARM 1% N76744 001 May 23, 2007 May NEWA
TETRACYCLINE HYDROCHLORIDE
FIBER, EXTENDED RELEASE; PERIODONTAL
ACTISITE
>D> @ ALZA 12.7MG/FIBER N50653 001 Mar 25, 1994 May CAHN
>A> @ ON SITE 12.7MG/FIBER N50653 001 Mar 25, 1994 May CAHN
THIORIDAZINE HYDROCHLORIDE
CONCENTRATE; ORAL
>D> THIORIDAZINE HYDROCHLORIDE INTENSOL
>D> AA ROXANE 30MG/ML N88941 001 Dec 16, 1985 May DISC
>A> @ 30MG/ML N88941 001 Dec 16, 1985 May DISC
>D> AA 100MG/ML N88942 001 Dec 16, 1985 May DISC
>A> @ 100MG/ML N88942 001 Dec 16, 1985 May DISC
TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
TARKA
>D> + ABBOTT 1MG;240MG N20591 003 Oct 22, 1996 May CRLD
>A> 1MG;240MG N20591 003 Oct 22, 1996 May CRLD
>D> + 2MG;180MG N20591 001 Oct 22, 1996 May CRLD
>A> 2MG;180MG N20591 001 Oct 22, 1996 May CRLD
>D> + 2MG;240MG N20591 004 Oct 22, 1996 May CRLD
>A> 2MG;240MG N20591 004 Oct 22, 1996 May CRLD
VERAPAMIL HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL
VERELAN
>D> AB + ELAN DRUG 120MG N19614 001 May 29, 1990 May CRLD
>A> AB 120MG N19614 001 May 29, 1990 May CRLD
>D> AB + 180MG N19614 003 Jan 09, 1992 May CRLD
>A> AB 180MG N19614 003 Jan 09, 1992 May CRLD
>D> AB + 240MG N19614 002 May 29, 1990 May CRLD
>A> AB 240MG N19614 002 May 29, 1990 May CRLD
ZICONOTIDE
INJECTABLE; INTRATHECAL
PRIALT
>D> + ELAN PHARMS 100UGM/1ML(100MG/ML) N21060 002 Dec 28, 2004 May CPOT
>A> + 100UGM/1ML(100UGM/ML) N21060 002 Dec 28, 2004 May CPOT
>D> + 500UGM/20ML(25MG/ML) N21060 001 Dec 28, 2004 May CPOT
>A> + 500UGM/20ML(25UGM/ML) N21060 001 Dec 28, 2004 May CPOT
>D> + 500UGM/5ML(100MG/ML) N21060 004 Dec 28, 2004 May CPOT
>A> + 500UGM/5ML(100UGM/ML) N21060 004 Dec 28, 2004 May CPOT
ZIDOVUDINE
CAPSULE; ORAL
ZIDOVUDINE
>A> AB CIPLA LTD 100MG N78349 001 May 23, 2007 May NEWA
ZILEUTON
>A> TABLET, EXTENDED RELEASE; ORAL
>A> ZYFLO CR
>A> + CRITICAL 600MG N22052 001 May 30, 2007 May NEWA
ZOLPIDEM TARTRATE
TABLET; ORAL
ZOLPIDEM TARTRATE
>A> AB WOCKHARDT 5MG N78426 001 May 15, 2007 May NEWA
>A> AB 10MG N78426 002 May 15, 2007 May NEWA
BROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE/BROMPHENIRAMINE MALEATE
>D> + ALZA 16MG;240MG N19672 001 Mar 29, 1996 May DISC
>A> @ 16MG;240MG N19672 001 Mar 29, 1996 May DISC
NICOTINE POLACRILEX
GUM, CHEWING; BUCCAL
NICOTINE POLACRILEX
>A> PERRIGO R AND D EQ 2MG BASE N78547 001 May 24, 2007 May NEWA
>A> EQ 4MG BASE N78546 001 May 24, 2007 May NEWA
PSEUDOEPHEDRINE HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
>D> EFIDAC 24 PSEUDOEPHEDRINE HYDROCHLORIDE
>D> + ALZA 240MG N20021 002 Dec 15, 1992 May CTNA
>A> SUDAFED 24 HOUR
>A> + ALZA 240MG N20021 002 Dec 15, 1992 May CTNA
Back
to Top
Back to Additions/Deletions Index
Date created: June 6, 2007; updated August 8, 2007 |
![](https://webarchive.library.unt.edu/eot2008/20090118123522im_/http://www.fda.gov/cder/templates/graphics/dot_clear.gif) |